GlassScriptPhysician profile
Christopher R Ramos
NPI 1740507425
$2,036.98
in general payments reported to CMS, 2019-2025
8 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $249 · 2023: $229 · 2024: $1,278 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,005 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,005.25 |
| Food and Beverage | $782.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,322.76 | 2023-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Angiodynamics, INC. | $249.19 | 2022 | |
| Boston Scientific Corporation | $186.17 | 2025 | Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $155.26 | 2024 | Esprit |
| Ets Wound Care LLC | $32.83 | 2025 | Mirragen Advanced Wound Matrix |
| Lemaitre Vascular, INC. | $32.62 | 2025 | Lemaitre Embolectomy Catheter, Pruitt Irrigation Occlusion Catheter |
| Imperative Care, INC | $29.53 | 2025 | Symphony Catheter |
| Silk Road Medical, INC. | $28.62 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.